Table 3.
Symptoms, laboratory and chest CT results of patients with fecal positive and negative SARS-CoV-2 RNA tests at the time of the last negative respiratory sample.
| Parameters | Patients with positive fecal tests (n = 20) | Patients with negative fecal tests (n = 49) | P value |
|---|---|---|---|
| Symptoms | |||
| Fever | 1 (5 %) | 1 (2.04 %) | |
| Dry cough | 1 (5 %) | 8 (16.33 %) | |
| Cough with sputum | 0 | 0 | |
| Muscle ache | 0 | 0 | |
| Sore throat | 0 | 0 | |
| Breathlessness | 0 | 0 | |
| Chest tightness | 0 | 0 | |
| Fatigue | 0 | 1 (2.04 %) | |
| Headache | 0 | 0 | |
| Nausea and vomiting | 0 | 1 (2.04 %) | |
| Diarrhea | 1 (5 %) | 1 (2.04 %) | |
| Laboratory results | |||
| CRP,0∼8 mg/L | 0.57 (0.22–1.725) | 1.14 (0.43–2.95) | 0.074 |
| >8 | 1 (5 %) | 6 (12.24 %) | 0.642 |
| Leukocyte counts4 −10 × 10^9/L |
4.67 (3.98–6.07) | 5.4 (4.53–6.81) | 0.08 |
| >10 | 0 | 2 (4.08 %) | 0.9 |
| Neutrophil counts 1.8-6.3 × 10^9/L |
2.82 (1.68–3.54) | 3.33 (2.57–4.67) | 0.031 |
| >6.3 | 0 | 3 (6.12 %) | 0.631 |
| Lymphocyte counts 1.1–3.2 × 10^9/L |
1.74 (1.5–1.89) | 1.53 (1.21–1.95) | 0.146 |
| <1.1 | 1 (5 %) | 6 (12.24 %) | 0.642 |
| ALT, 0–69IU/L | 35.0(23.0–47.75) | 33.0(25.0–50.50) | 0.548 |
| >69 | 1 (5 %) | 9 (18.37 %) | 0.292 |
| ALB, 35−55 g/L | 42.3 (38.625–43.65) | 39.3 (36.85–41.45) | 0.010 |
| <35 | 1 (5 %) | 5 (10.20 %) | 0.822 |
| Involved lobes (chest CT) | |||
| Right upper lobe | 8 (40 %) | 29 (59.18 %) | |
| Right middle lobe | 11 (55 %) | 35 (71.43 %) | |
| Right lower lobe | 14 (70 %) | 44 (89.80 %) | |
| Left upper lobe | 10 (50 %) | 33 (67.35 %) | |
| Left lower lobe | 13 (65 %) | 39 (79.59 %) | |
| Bilateral lung involvement | 13 (65 %) | 41 (83.67 %) | |
| Percentage of improvement (chest CT) | |||
| Right upper lobe | 8 (40 %) | 26 (53.14 %) | |
| Right middle lobe | 10 (50 %) | 31 (63.27 %) | |
| Right lower lobe | 14 (70 %) | 41 (83.67 %) | |
| Left upper lobe | 10 (50 %) | 31 (63.27 %) | |
| Left lower lobe | 13 (65 %) | 35 (71.43 %) | |
| Percentage of progress (chest CT) | |||
| Right upper lobe | 0 | 1 (2.04 %) | |
| Right middle lobe | 0 | 2 (4.08 %) | |
| Right lower lobe | 0 | 1 (2.04 %) | |
| Left upper lobe | 0 | 0 | |
| Left lower lobe | 0 | 2 (4.08 %) | |
| complete absorbed lobes (chest CT) | |||
| Right upper lobe | 3 (15 %) | 1 (2.04 %) | |
| Right middle lobe | 1 (5 %) | 1 (2.04 %) | |
| Right lower lobe | 2 (10 %) | 1 (2.04 %) | |
| Left upper lobe | 3 (15 %) | 3 (6.12 %) | |
| Left lower lobe | 1 (5 %) | 1 (2.04 %) | |
Data are presented as interquartile ranges (IQRs), numbers and percentages.
CRP, C-reactive protein; ALT, alanine transaminase; ALB, albumin.